Clinical Research

Thermo Fisher Scientific Introduces Gibco™ Efficient-Pro™ Medium (+) Insulin to Boost Titers by Up to 61% and Streamline Bioproduction

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines Thermo Fisher Sci...

 September 16, 2025 | News

Alphamab Oncology’s NDA for KN026 Accepted by NMPA for HER2-Positive Gastric Cancer

Alphamab Oncology announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed ...

 September 15, 2025 | News

Leads Biolabs Doses First Patient in Phase 1b/II Trial of Opamtistomig for Advanced Melanoma

Nanjing Leads Biolabs Co., announced the first patient has been successfully dosed in a Phase 1b/II clinical trial (NCT07099430) evaluating Opamt...

 September 15, 2025 | News

Shineco Strikes $8.7M R&D Deal and Builds Global Bridge with Singapore’s BICC

Shineco Inc., a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, announced two major strategic advances. Its subs...

 September 15, 2025 | News

Kazia’s Paxalisib Disrupts Circulating Tumour Cell Clusters in HER2-Positive Metastatic Breast Cancer Study

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program...

 September 12, 2025 | News

Cytiva and WhiteLab Genomics Partner to Accelerate AAV Genomic Medicine Development

Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timelin...

 September 11, 2025 | News

Telix Doses First Patient In Phase 3 BiPASS™ Trial Evaluating Illuccix® And Gozellix® For Prostate Cancer Diagnosis

Telix Pharmaceuticals Limited  announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix&re...

 September 11, 2025 | News

Innorna completes Phase II enrollment for IN006, the first bivalent RSV mRNA vaccine

Innorna  announced the completion of enrollment and vaccination in its Phase II clinical trial for IN006, the world’s first bivalent respiratory...

 September 11, 2025 | News

XtalPi and PharmaEngine Advance AI-Designed PRMT5 Inhibitor PEP08 into Phase 1 Trials for Solid Tumours

XtalPi Inc. (Stock Code: 2228.HK) has announced that PEP08, a next-generation PRMT5 inhibitor candidate developed through its AI drug discovery collaborati...

 September 10, 2025 | News

iRegene Secures Over RMB 300 Million in Landmark Series B+ Financing to Advance First-in-Class iPSC Cell Therapies

iRegene Therapeutics (Chengdu) Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, ...

 September 10, 2025 | News

Metabolon Partners with China Kadoorie Biobank to Advance Landmark Multiomics Study on Common Diseases

The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common disea...

 September 10, 2025 | News

KBI Biopharma and Infinimmune Partner to Advance Manufacturing of Lead Human-First Antibody IFX-101

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotec...

 September 09, 2025 | News

Epigenic Therapeutics Raises $60 Million in Series B Financing to Advance Epigenetic Medicine Pipeline

Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series ...

 September 09, 2025 | News

AstraZeneca’s FLAURA2 Trial Confirms TAGRISSO Plus Chemotherapy Extends Survival in EGFR-Mutated Lung Cancer

FLAURA2 final overall survival analysis reinforces the favorable benefit-risk profile of this combination Results underscore TAGRISSO as 1st-line s...

 September 08, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close